Get Email Alerts
Other Names for Idiopathic Pulmonary Fibrosis
- Idiopathic diffuse interstitial pulmonary fibrosis
- Pulmonary fibrosis of unknown cause
- Pulmonary fibrosis
- Cryptogenic fibrosing alveolitis
- Usual interstitial pneumonitis
- Diffuse fibrosing alveolitis
Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. To find clinical trials that are currently underway for Idiopathic Pulmonary Fibrosis, visit www.clinicaltrials.gov.
October 21, 2011
Commonly used three-drug regimen for idiopathic pulmonary fibrosis found harmful
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic pulmonary fibrosis (IPF) for safety concerns.
The NHLBI updates Health Topics articles on a biennial cycle based on a thorough review of research findings and new literature. The articles also are updated as needed if important new research is published. The date on each Health Topics article reflects when the content was originally posted or last revised.
Twitter
Facebook
YouTube